← back to search

María E.R. García-Rendueles

Universidade de Santiago de Compostela · ES
Area of research
Endocrinology, Diabetes and Metabolism · Cell Biology
Research interest
Research interests include Cancer research, Thyroid cancer, Biology, HRAS, Carcinogenesis, and Receptor tyrosine kinase.
h-index
—
citations
473
works
3
NIH funding
—
primary concept
—
email
✉ Find email ↗

Recent publications

Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers
Cancer Research 2018cited by 79position: middledoi
<i>NF2</i> Loss Promotes Oncogenic RAS-Induced Thyroid Cancers via YAP-Dependent Transactivation of RAS Proteins and Sensitizes Them to MEK Inhibition
Cancer Discovery 2015cited by 151position: firstdoi
Identification of kinase fusion oncogenes in post-Chernobyl radiation-induced thyroid cancers
Journal of Clinical Investigation 2013cited by 243position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Jeffrey A. Knauf · Cleveland Clinic Lerner College of Medicine3 papers (2013–2018)James A. Fagin · Specialized Dentistry of New York3 papers (2013–2018)Francesca Voza · Twitter (United States)2 papers (2013–2015)— · 2 papers (2013–2015)Adriana Heguy · New York Genome Center2 papers (2013–2015)Brian R. Untch · Memorial Sloan Kettering Cancer Center2 papers (2015–2018)Agnès Viale · Kraft Heinz (United States)2 papers (2013–2015)Ronald Ghossein · Memorial Sloan Kettering Cancer Center2 papers (2015–2018)— · 1 papers (2015–2015)Vicki E. Smith · University of Birmingham1 papers (2015–2015)Alan L. Ho · Merck Institute for Science Education1 papers (2018–2018)Gnana P. Krishnamoorthy · University of Naples Federico II1 papers (2018–2018)— · 1 papers (2018–2018)— · 1 papers (2018–2018)Nicholas D. Socci · Memorial Sloan Kettering Cancer Center1 papers (2018–2018)Barry S. Taylor · University of Maryland, Baltimore1 papers (2015–2015)Filippo G. Giancotti · Columbia University1 papers (2015–2015)— · 1 papers (2013–2013)Ian Ganly · Pediatrics and Genetics1 papers (2015–2015)Kety Huberman · Memorial Sloan Kettering Cancer Center1 papers (2015–2015)